Inference for Surrogate Endpoint Validation in the Binary Case

REFERENCES

• Bebu, I., Seillier-Moiseiwitch, F., Mathew, T. (2009). Generalized confidence intervals for ratios of regression coefficients with applications to bioassays. Biometrical Journal 51:1047–1058.
   PubMed Web of Science ®Google Scholar
• Bebu, I., Tate, J., Rimland, D., Mesner, O., Macalino, G. E., Ganesan, A., Okulicz, J. F., Bavaro, M., Weintrob, A. C., Agan, B. K., Infectious Disease Clinical Research Program HIV Working Group. (2014). The VACS Index predicts mortality in a young, healthy HIV population starting highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes 65(2):226–230.
   PubMed Web of Science ®Google Scholar
• Burzykowski, T., Molenberghs, G., Buyse, M. (2005). The Evaluation of Surrogate Endpoints. New York: Springer.
   Google Scholar
• Buyse, M., Molenberghs, G. (1998). Criteria for the validation of surrogate endpoints in randomized experiments. Biometrics 54:1014–1029.
   PubMed Web of Science ®Google Scholar
• Frangakis, C. E., Rubin, D. B. (2002). Principal stratification in causal inference. Biometrics 58:21–29.
   PubMed Web of Science ®Google Scholar
• Freedman, L. S., Graubard, B. I., Schatzkin, A. (1992). Statistical validation of intermediate endpoints for chronic diseases. Statistics in Medicine 11:167–178.
   PubMed Web of Science ®Google Scholar
• Hannig, J. (2009). On generalized fiducial inference. Statistica Sinica 19:491–544.
   Web of Science ®Google Scholar
• Huang, B., Sivaganesan, S., Succop, P., Goodman, E. (2004). Statistical assessment of mediation effects for logistic mediation models. Statistics in Medicine 23:2713–2728.
   PubMed Web of Science ®Google Scholar
• Justice, A.C., Freiberg, M. S., Tracy, R., Kuller, L., Tate, J. P., Goetz, M. B., Fiellin, D.A., Vanasse, G. J., Butt, A. A., Rodriguez-Barradas, M. C., Gilbert, C., Oursler, K. A., Deeks, S. G., Bryant, K., VACS Project Team. (2012). Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV? Clinical Infectious Diseases 54:984–994.
   PubMed Web of Science ®Google Scholar
• Krishnamoorthy, K., Lee, M. (2010). Inference for functions of parameters in discrete distributions based on fiducial approach: binomial and Poisson cases. Journal of Statistical Planning and Inference 140:1182–1192.
   Web of Science ®Google Scholar
• Lin, D. Y., Fleming, T. R., DeGruttola, V. (1997). Estimating the proportion of treatment effect explained by a surrogate marker. Statistics in Medicine 16:1515–1527.
   PubMed Web of Science ®Google Scholar
• MacKinnon, D. P., Lockwood, C. M., Brown, C. H., Wang, W., Hoffman, J. M. (2007). The intermediate endpoint effect in logistic and probit regression. Clinical Trials 4:499–513.
   PubMed Web of Science ®Google Scholar
• Marconi, V. C., Grandits, G. A., Weintrob, A. C., Chun, H., Landrum, M. L., Ganesan, A., Okulicz, J. F., Crum-Cianflone, N., O'Connell, R. J., Lifson, A., Wortmann, G. W., Agan, B. K., Infectious Disease Clinical Research Program HIV Working Group. (2010). Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: The U.S. Military HIV Natural History Study. AIDS Research and Therapy 7:14.
   PubMedGoogle Scholar
• Prentice, R. L. (1989). Surrogate endpoints in clinical trials: definition and operational criteria. Statistics in Medicine 8:431–440.
   PubMed Web of Science ®Google Scholar
• Taylor, J. M. G., Wang, Y., Thiébaut, R. (2005). Counterfactual links to the proportion of treatment effect explained by a surrogate marker. Biometrics 61:1102–1111.
   PubMed Web of Science ®Google Scholar
• Tate, J. P., Justice, A. C., Hughes, M. D., Bonnet, F., Reiss, P., Mocroft, A., Nattermann, J., Lampe, F. C., Bucher, H. C., Sterling, T. R., Crane, H. M., Kitahata, M. M., May, M., Sterne, J. A. (2013). An internationally generalizable risk index for mortality after one year of antiretroviral therapy. AIDS 27:563–572.
   PubMed Web of Science ®Google Scholar
• VanderWeele, T. J., Vansteelandt, S. (2010). Odds ratios for mediation analysis for a dichototuous outcome. American Journal of Epidemiology 172:1339–1348.
   PubMed Web of Science ®Google Scholar
• Wang, Y., Taylor, J. M. G. (2002). A measure of the proportion of treatment effect explained by a surrogate marker. Biometrics 58:803–812.
   PubMed Web of Science ®Google Scholar
• Weerahandi, S. (1993). Generalized confidence intervals. Journal of the American Statistical Association 88:899–905.
   Web of Science ®Google Scholar
• Weerahandi, S. (1995). Exact Statistical Methods for Data Analysis. New York: Springer-Verlag.
   Google Scholar
• Weerahandi, S. (2004). Generalized Inference in Repeated Measures: Exact Methods in MANOVA and Mixed Models. New York: Wiley.
   Google Scholar